Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma

There is no standard third-line or further systemic treatment for patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma (NPC). Metronomic oral cyclophosphamide provides an acceptable and cheap option for these heavily pretreated patients who had limited ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Victor H.F., Kwong, Dora L.W., Lam, Ka-On, Lai, Yu-Ching, Li, Yun, Tong, Chi-Chung, Ho, Patty P.Y., Chan, Wing-Lok, Wong, Lai-San, Leung, Dennis K.C., Chan, Sum-Yin, Chan, Fong-Ting, Leung, To-Wai, Lee, Anne W.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403079/
https://www.ncbi.nlm.nih.gov/pubmed/28403082
http://dx.doi.org/10.1097/MD.0000000000006518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403079/
https://www.ncbi.nlm.nih.gov/pubmed/28403082
http://dx.doi.org/10.1097/MD.0000000000006518

Ejemplares similares